GMP failures often stem from recurring, preventable control weaknesses. This article outlines the 10 most common GMP mistakes observed during inspections and explains how to strengthen training, documentation, validation, and oversight systems before findings escalate.

GMP and cGMP are often used interchangeably, but the distinction matters. This article explains what the “c” in cGMP means, how regulators interpret it, and why maintaining current, defensible systems is essential for inspection readiness.

As pharmaceutical manufacturing becomes more digital and global, GMP remains the foundation of quality control. This article explains why GMP still matters in 2026 and how evolving technologies, risk-based thinking, and inspection trends are reshaping compliance expectations.

GMP defines how pharmaceutical systems maintain control. This guide explains how regulators evaluate GMP compliance, what inspection readiness looks like, and how control systems function in practice.